In MAPS’s trials, scientists dose PTSD sufferers with copyright right before guiding them via a psychotherapy session—they’ve found evidence the drug helps patients faucet in the trauma in the core of their dysfunction without needing to relive it in the same visceral, terrifying way they would if they were sober. MAPS would need to incorpora… Read More